Maxim Group Cuts Price Target on Galena Biopharma (GALE) After Meeting with Management
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Pre-Open Stock Movers 07/08: (EBIO) (MITL) (CUDA) Higher; (JUNO) (GALE) (KITE) Lower (more...)
July 8, 2016 9:28 AM EDTToday's Pre-Open Stock Movers
Galena Biopharma (GALE) Prices 28M Common Stock Direct Offering at $0.45/Share
July 8, 2016 7:05 AM EDTGalena Biopharma, Inc. (Nasdaq: GALE) entered into securities purchase agreements with certain institutional investors providing for the issuance of 28,000,000 shares of common stock at a purchase price per share of $0.45 in a registered direct offering, and warrants to purchase up to 14,000,000 shares of... More
